Expert led session designed to help life sciences professionals navigate the evolving expectations for packaging and delivery system evaluation under USP <382>
MINNEAPOLIS, MN – April 28, 2026 – USP <382> marks a fundamental shift from traditional component-based qualification to a comprehensive, system-level approach for parenteral packaging and delivery systems. Christian Collazo-Sarra, Manager at Pace® Life Sciences, a division of Pace®, a Science and Technology company, will explore how responsibility for demonstrating functional suitability is increasingly placed on CDMOs and finished product manufacturers, rather than solely on component suppliers.
The free, virtual webinar will be held on Wednesday, April 29 at 11:00 AM EST. Attendees will gain practical insights into system-level functionality testing, its integration with container closure integrity testing (CCIT), and strategies to meet USP <382> requirements across development and commercialization stages.
Key Learning Objectives:
- Understand the responsibility shift under USP <382>
- Recognize the importance of system-level functionality testing
- Learn how functional testing and complete system CCIT work together
Who Should Attend:
- CDMO and finished product manufacturers
- Packaging, device, and combination product engineers
- Quality, regulatory, and compliance professionals
- Analytical and contract testing laboratory teams
- Component and material suppliers
Register Here: https://info.pacelabs.com/webinar-evaluating-package-system-usp-382-register
Pace® is a portfolio company of Leonard Green & Partners and Los Angeles-based Aurora Capital Partners.
About Christian Collazo-Sarra
Christian Collazo-Sarra is a manager at the Pace® Life Sciences laboratory in Lebanon, NJ focusing on CCIT, drug delivery device functional characterization, and package distribution testing services. He has over 7 years of experience in contract testing across multiple disciplines in the pharmaceutical industry and is a graduate of Rutgers School of Engineering, with a BS in Biomedical Engineering.
About Pace® Life Sciences
Pace® Life Sciences provides a full suite of contract CMC development, clinical trials materials manufacturing, regulatory compliance, consulting, and facility support services to the pharmaceutical, biopharmaceutical, and gene therapy industries. Our network of CDMO sites consists of GMP analytical testing laboratories and manufacturing support service centers. Our experienced, highly trained industry experts and our investment in state-of-the-art development and manufacturing facilities emphasize our commitment to efficiently advancing client programs through the clinic to commercialization. We are dedicated to delivering the best and most reliable services with positive customer experiences across all channels of our business.